Company

Sharp Edge Labs Inc.

Pennsylvania-based Sharp Edge Labs Inc. develops biosensors and small molecule drugs for patients with protein trafficking disorders.

About

Founded in 2010 and based in Pennsylvania, US, Sharp Edge Labs, Inc. is a biotechnology company that develops biosensors for patients with protein trafficking disorders. It develops small molecule drugs that restore the function of mutated proteins, using its CoreX, AlloChem and Disco/Mine technologies. In August 2019 the company raised USD 3.547 million in venture funding, and it is at the Series C stage.

4Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in